Nikita joined Versant in February 2024 as a Principal based in Basel, Switzerland. She is focused on supporting both existing Versant companies as well as future opportunities in Europe and North America.
Nikita previously was Mergers and Acquisitions Director at Novartis, where she successfully led and closed the acquisitions of Chinook Therapeutics, Calypso Biotech and SanReno Therapeutics, and contributed to multiple other strategic transactions across different therapeutic areas. Before Novartis, Nikita was a Mergers and Acquisitions Analyst at Sandoz, and prior to that held business development positions at Axalta.
She received an MBA from Symbiosis International University.